GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Winston Medical Supply Co Ltd (ROCO:6817) » Definitions » Debt-to-EBITDA

Winston Medical Supply Co (ROCO:6817) Debt-to-EBITDA : 0.44 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Winston Medical Supply Co Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Winston Medical Supply Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was NT$51.3 Mil. Winston Medical Supply Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was NT$56.1 Mil. Winston Medical Supply Co's annualized EBITDA for the quarter that ended in Dec. 2023 was NT$246.2 Mil. Winston Medical Supply Co's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 0.44.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Winston Medical Supply Co's Debt-to-EBITDA or its related term are showing as below:

ROCO:6817' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.47   Med: 1.42   Max: 17.32
Current: 0.47

During the past 7 years, the highest Debt-to-EBITDA Ratio of Winston Medical Supply Co was 17.32. The lowest was 0.47. And the median was 1.42.

ROCO:6817's Debt-to-EBITDA is ranked better than
73.37% of 661 companies
in the Drug Manufacturers industry
Industry Median: 1.7 vs ROCO:6817: 0.47

Winston Medical Supply Co Debt-to-EBITDA Historical Data

The historical data trend for Winston Medical Supply Co's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Winston Medical Supply Co Debt-to-EBITDA Chart

Winston Medical Supply Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial 8.15 1.42 0.68 0.53 0.47

Winston Medical Supply Co Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.90 0.66 0.46 0.82 0.44

Competitive Comparison of Winston Medical Supply Co's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Winston Medical Supply Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Winston Medical Supply Co's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Winston Medical Supply Co's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Winston Medical Supply Co's Debt-to-EBITDA falls into.



Winston Medical Supply Co Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Winston Medical Supply Co's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(51.272 + 56.057) / 228.325
=0.47

Winston Medical Supply Co's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(51.272 + 56.057) / 246.198
=0.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Dec. 2023) EBITDA data.


Winston Medical Supply Co  (ROCO:6817) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Winston Medical Supply Co Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Winston Medical Supply Co's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Winston Medical Supply Co (ROCO:6817) Business Description

Traded in Other Exchanges
N/A
Address
117 Renai Street, Yanzhouli, Yongkang District, Tainan, TWN, 710
Winston Medical Supply Co Ltd is a manufacturer of medical products. It produces sterile ophthalmic preparations, hormone preparations and healthy products.

Winston Medical Supply Co (ROCO:6817) Headlines

No Headlines